Cargando…
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
This study independently confirms in vivo in the JR5558 mouse model of aberrant retinal angiogenesis, that simultaneous VEGF‐A and ANG‐2 neutralization using a bispecific anti‐VEGF‐A/ANG‐2 antibody reduces vascular leakage, immune reactivity and apoptosis more effectively than either agent alone.[Im...
Autores principales: | Foxton, Richard H, Uhles, Sabine, Grüner, Sabine, Revelant, Franco, Ullmer, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505683/ https://www.ncbi.nlm.nih.gov/pubmed/31040126 http://dx.doi.org/10.15252/emmm.201810204 |
Ejemplares similares
-
Choroidal Neovascularization Following Epiretinal Membrane Peeling
por: Bae, Ki Woong, et al.
Publicado: (2015) -
Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage
por: Hwang, Da-Eun, et al.
Publicado: (2016) -
Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusion
por: Canonica, Jérémie, et al.
Publicado: (2023) -
CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization
por: Chung, Sook Hyun, et al.
Publicado: (2022) -
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
por: Barth, T., et al.
Publicado: (2019)